Colin Cooper

Colin Cooper is a Professor of Cancer Genetics at the Norwich Medical School, University of East Anglia. He is also a member of the Metabolic Health and Cancer Studies research groups. His work focuses on genomic evolution, tumor microbiome dynamics, and biomarker development for prostate cancer and musculoskeletal health.

Cooper’s recent research explores the interplay between cancer genetics and microbial communities, emphasizing their role in prognosis and treatment outcomes. He investigates clonal evolution in tumors, mutational signatures, and non-invasive diagnostic tools like urinary extracellular vesicles. His collaborations span genomics, microbiology, and clinical applications.

• 2025: Causes of evolutionary divergence in prostate cancer (Genomics, Precision Medicine)
• 2024: Applications of urinary extracellular vesicles... (Biomarker Development, Liquid Biopsy)
• 2023: Caution regarding pan-cancer microbial structure (Methodological Considerations, Microbiome Analysis)

In 2022, Cooper received the European Urology Oncology SoMe Award for his contributions. His work is frequently cited and has been featured in media outlets globally, highlighting his impact on cancer and aging research.